Khadka Sushmita, Kasireddy Vineela, Dhakal Pravash Kumar, Dadiboyina Chandrakala
Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA, USA.
J Community Hosp Intern Med Perspect. 2021 Jan 26;11(1):115-119. doi: 10.1080/20009666.2020.1843237.
The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and responses to them, comorbidities and cost associated with the treatment. We hereby review the newer approaches in the treatment of ITP.
对于血液科医生而言，复发或难治性免疫性血小板减少症（ITP）患者的管理仍然具有挑战性。虽然有多种药物可供使用，但很大程度上是基于患者的偏好、副作用、既往接受的治疗及其反应、合并症以及治疗相关费用进行个体化管理。我们在此回顾ITP治疗的新方法。
